LRH-1 was reported in previous studies to constantly exhibit nuclear localization and govern vital transcriptional programs of several types of malignancy, especially breast cancer (Bianco et al., 2014; Wang et al., 2018) and pancreatic cancer (Lin et al., 2014a). This evidence concerns the gene NR5A2 and breast carcinoma.